I

Immuron Limited

D
IMRN
USD
-0.09
(-4.5455%)
Market Closed
100.000
Volume
-0.0204
EPS
-
Div Yield
-4.167673
P/E
10,772,922.51
Market Cap
Today
-4.5455%
1 Week
-1.563%
1 Month
-18.534%
6 Months
-24.701%
12 Months
21.154%
Year To Date
-1.563%
All Time
0%

Title:
Immuron Limited

Sector:
Healthcare
Industry:
Biotechnology
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Do you need help or have a question?